Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNeometals Regulatory News (NMT)

Share Price Information for Neometals (NMT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 6.25
Bid: 6.00
Ask: 6.50
Change: 0.00 (0.00%)
Spread: 0.50 (8.333%)
Open: 6.25
High: 6.25
Low: 6.25
Prev. Close: 6.25
NMT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Final Stage of ELi™ Pilot Trial Commences

22 May 2024 07:00

RNS Number : 3397P
Neometals Ltd
22 May 2024
 

22 May 2024

Neometals Ltd

("Neometals" or "the Company")

Final Stage of ELi™ Pilot Trial Commences

Highlights

· Final Electrolysis stage of ELi™ Process pilot trials has commenced in Canada at NESi, the testing facility of electrolyser vendor, NORAM;

· The test work will electrolyse a purified lithium chloride solution from an operating South American brine source and produce lithium hydroxide as the primary product; and

· The long-duration (1000hr) component of the trial will provide data confirming expected power consumption, membrane life and product quality to support ongoing technology licensing activities.

Sustainable process technology developer, Neometals Ltd (ASX: NMT & AIM: NMT) ("Neometals" or "the Company"), is pleased to announce the commencement of the final Electrolysis stage of a pilot test work program ("Electrolysis Pilot") by Reed Advanced Materials Pty Ltd ("RAM"). RAM, the 70:30 Neometals incorporated joint venture, with Mineral Resources Ltd, is commercialising its proprietary ELi™ Process ("ELi™").

ELi™ uses electricity to convert lithium chloride solutions into lithium hydroxide monohydrate ("Primary Product") in a conventional chlor-alkali cell, replacing large volumes of reagents required in the industry standard, chemical precipitation flowsheet. ELi™ has the potential to deliver users a step-change in operating costs[1].

Figure 1 - Schematic showing a comparison of the conventional flowsheet for the production of lithium hydroxide from brines with the patented ELi™ process.

 

 

The Electrolysis Pilot will electrolyse lithium chloride brine from RAM's successful 2023 'purification' testing campaign undertaken by SGS[2]. RAM has completed pre-treatment and commenced the 1,000hr electrolysis membrane durability test at NESi, the testing facility of electrolyser vendor NORAM. This long-duration test work is expected to be completed in July 2024 and will provide more accurate estimates of electrolyser power consumption and membrane life, the two major variable ELi operating costs.

Additional testing in a full industrial height electrolysis cell will deliver a fluid flow profile and cell dynamics to predict likely performance at commercial scale. The intermediate electrolysis product solution will be evaporated and crystallised into finished Primary Product by equipment vendor JordProxa (accessory by-products include hydrogen and chlorine gas). The Electrolysis Pilot is expected to confirm battery quality results for the Primary Product which were achieved in previous test work. and the Electrolysis Pilot will also provide samples for selected cathode producers to enable a complete technical and economic assessment by the brine feedstock provider.

RAM continues to evaluate other third-party brines as part of its Lithium Chemical technology licensing business model. RAM holds 19 granted patents in the principal lithium producing jurisdictions and has a further 15 pending national phase patents at various stages of prosecution globally.

Authorised on behalf of Neometals by Christopher Reed, Managing Director.

-ENDS-

For more information, please contact:

 

Neometals Ltd

Chris Reed, Managing Director & Chief Executive Officer

 +61 8 9322 1182

Jeremy McManus, General Manager - IP & IR

 +61 8 9322 1182

 

Cavendish Capital Markets Ltd - NOMAD & Broker

 

Neil McDonald

+44 (0)131 220 9771

Peter Lynch

+44 (0)131 220 9772

Adam Rae

+44 (0)131 220 9778

 

About Neometals

Neometals facilitates sustainable critical material supply chains and reduces the environmental burden of traditional mining in the global transition to a circular economy.

The Company is commercialising a portfolio of sustainable processing solutions that recycle and recover critical materials from high-value waste streams.

Neometals' core focus is on the commercialisation of its patented, Lithium-ion Battery ("LiB") Recycling technology (50% NMT), under a plant supply and technology licensing business model. Primobius GmbH is the 50:50 incorporated JV with 150-year-old German plant builder, SMS group GmbH, that is commercialising the technology. Primobius is building a 2,500tpa recycling plant for Mercedes-Benz under a long-term Cooperation Agreement. It also operates its own LiB disposal service in Germany and plans to offer its first commercial 21,000tpa plant to North American licensee, Stelco, in JunQ 2025.

Neometals is also developing two advanced battery materials technologies for commercialisation under low-risk, low-capex technology licensing business models:

· Lithium Chemicals (70% NMT) - Patented ELi™ electrolysis process, co-owned 30% by Mineral Resources Ltd, to produce battery quality lithium hydroxide from brine and/or hard-rock feedstocks at lowest quartile operating costs. Pilot scale test work and Engineering Cost Study update planned for completion in DecQ 2024; and

· Vanadium Recovery (100% NMT) - Patent pending hydrometallurgical process to produce high-purity vanadium pentoxide from steelmaking by-product ("Slag") at lowest-quartile operating cost and carbon footprint.

For further information visit www.neometals.com.au

 


[1] For full details refer to Neometals ASX announcement dated 26th April and titled "Lithium - Exceptional Engineering Cost Study Results"

[2] For full details refer to Neometals ASX announcement dated 10th November 2023 and titled "Successful ELiTM Purification Pilot Trial"

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDFLFVSETILFIS
Date   Source Headline
6th Jun 20248:34 amRNSDirector/PDMR Shareholding
4th Jun 20247:00 amRNSPrecious Metals Due Diligence Update
3rd Jun 20247:00 amRNSAppointment of Chief Financial Officer
29th May 20247:00 amRNSNeometals Strengthens its Senior Management Team
28th May 20247:00 amRNSOption to acquire Precious Metals Process & Plant
22nd May 20247:00 amRNSFinal Stage of ELi™ Pilot Trial Commences
15th May 202412:38 pmRNSNeometals Shares Commence Trading on OTCQX market
24th Apr 20247:01 amRNSQuarterly Cashflow Report
24th Apr 20247:00 amRNSQuarterly Activities Report
18th Apr 202410:24 amRNSChange in Substantial Holding
21st Mar 20247:00 amRNSLithium Chemicals Update
15th Mar 202412:26 pmRNSChange in Substantial Holding
14th Mar 20248:57 amRNSCorporate Presentation
14th Mar 20247:56 amRNSHalf-year Report
4th Mar 20249:35 amRNSIssue of Shares
13th Feb 20247:03 amRNSSpargos Exploration Update
2nd Feb 20247:00 amRNSCorporate Presentation
25th Jan 20247:07 amRNSQuarterly Cashflow Report
25th Jan 20247:06 amRNSQuarterly Activities Report
23rd Jan 20245:17 pmRNSDirector/PDMR Shareholding
10th Jan 20247:00 amRNSMercedes-Benz Refinery Purchase Order
22nd Dec 20237:00 amRNSPrimobius Commercial Update
19th Dec 20237:34 amRNSPrimobius Achieves 85% Carbon Emissions Reduction
18th Dec 20231:45 pmRNSDirector & PDMR Participation in Entitlement Offer
13th Dec 20237:00 amRNSResults of Non-Renounceable Entitlement Offer
6th Dec 202312:24 pmRNSDirector/PDMR Shareholding
29th Nov 20237:39 amRNSEntitlement Offer Opens
27th Nov 20231:15 pmRNSDirector/PDMR Dealings
24th Nov 202312:18 pmRNSChairman's AGM 2023 Address
24th Nov 202312:16 pmRNSResults of Annual General Meeting
23rd Nov 20237:00 amRNSNeometals Closes A$9.0 Million Placement
20th Nov 20234:45 pmRNSProposed Equity Raise to Advance Primobius
20th Nov 202311:56 amRNSChange of Nominated Adviser
20th Nov 20239:20 amRNSAnnual General Meeting - Withdrawal of Resolution
13th Nov 20237:38 amRNSNeometals Discovers Spodumene-bearing Pegmatite
10th Nov 20237:00 amRNSSuccessful ELi Purification Pilot Trial
8th Nov 20237:00 amRNSOutstanding Nickel Sulphate Purity for Primobius
30th Oct 20237:02 amRNSQuarterly cash flow report
30th Oct 20237:01 amRNSQuarterly Activities Report
30th Oct 20237:00 amRNSVanadium Recovery Strategy Update
23rd Oct 20237:28 amRNSNotice of Annual General Meeting
18th Oct 20231:57 pmRNSASX Aware Query
6th Oct 20237:02 amRNSBattery Recycling Expert to Lead NMT Recycling
4th Oct 20237:11 amRNSOutstanding Lithium Recovery Results for Primobius
3rd Oct 20238:33 amRNSLithium Chemicals Co-operation Update
3rd Oct 20237:00 amRNSRetail Investor Conference Participation
2nd Oct 20238:42 amRNSVanadium Recovery Project Update
2nd Oct 20238:33 amRNSBarrambie Offtake Update
29th Sep 20238:29 amRNSAnnual Financial Report
22nd Sep 20239:10 amRNSExtension of Managing Director's Contract

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.